Addyi reviews are mixed: flibanserin offers modest gains in sexual desire for premenopausal women with HSDD, but real side effects to weigh.
Addyi reviews are mixed, and the honest summary is that the drug helps some women a little and does nothing noticeable for others. Addyi is the brand name for flibanserin, an FDA-approved prescription pill for hypoactive sexual desire disorder (HSDD) in premenopausal women. In clinical trials, the average benefit was about one extra satisfying sexual event per month compared with placebo — real, but modest.
What Addyi Is and What It Is Not
Addyi is a non-hormonal pill taken once daily at bedtime. It acts on dopamine and serotonin pathways in the brain rather than on blood flow or hormones, which is why it is often called a "female Viagra" and why that label is misleading.
- FDA-approved in August 2015 for acquired, generalized HSDD in premenopausal women.
- Not approved for postmenopausal women.
- Not intended for low desire caused by relationship problems, untreated depression, medication side effects, or menopause.
- Available by prescription only — there is no over-the-counter version in the United States.
Because flibanserin reviews and Addyi reviews describe the same medication, searches for either term return very similar user experiences and the same clinical data.
What the Pivotal Trials Found
Two 24-week randomized trials of more than 2,000 premenopausal women with HSDD measured satisfying sexual events, sexual desire, and distress. Average improvements were small and consistent across both studies.
| Outcome over 24 weeks | Addyi (flibanserin) | Placebo |
|---|---|---|
| Satisfying sexual events per month | Increase of about 0.5–1.0 | Increase of about 0.3–0.6 |
| Sexual desire score | Increase of about 0.6–1.0 points | Increase of about 0.2–0.5 points |
| Distress about low desire | Larger reduction | Smaller reduction |
| Stopped treatment due to side effects | About 10% | About 6% |
These are averages, not predictions for any individual woman. A minority of participants reported a change they described as meaningful, and roughly one in ten stopped the drug because of side effects.
Addyi takes time to work. Most clinicians ask patients to give it at least four to eight weeks before judging whether it helps, and to stop if there is no improvement by eight weeks.
What Real-World Reviews Tend to Report
User reviews cluster around a few recurring themes. Positive reviews usually mention feeling more present, more spontaneous interest, and less distress — often after several weeks rather than days.
Negative reviews focus on side effects, cost, and logistics. Common complaints include dizziness, sleepiness, nausea, fatigue, and the inconvenience of a nightly pill combined with a strict no-alcohol rule.
Review sites skew toward strong experiences. Women who noticed nothing at all rarely take the time to post, so both five-star and one-star Addyi reviews overrepresent the extremes.
Side Effects and Safety Warnings
Addyi carries a boxed warning — the FDA's strongest — for severely low blood pressure and fainting, particularly when the drug is combined with alcohol.
- Avoid alcohol entirely while taking Addyi. Drinking can cause sudden hypotension and loss of consciousness.
- Common side effects include dizziness, drowsiness, nausea, fatigue, insomnia, and dry mouth.
- Do not drive or operate machinery until you know how the drug affects you; bedtime dosing lowers this risk.
- Addyi is contraindicated with strong CYP3A4 inhibitors such as ketoconazole and clarithromycin, and in people with liver impairment.
- Avoid grapefruit and grapefruit juice, which can raise blood levels of flibanserin.
Review every prescription, supplement, and herbal product with a pharmacist or physician before starting. Anyone with a history of fainting or low blood pressure should be evaluated carefully first.
How Addyi Compares With Other Options
Vyleesi (bremelanotide) is the other FDA-approved drug for HSDD in premenopausal women. It is an injected, as-needed medication taken about 45 minutes before sex, so it suits women who prefer occasional rather than daily treatment. Reading vyleesi reviews alongside a direct vyleesi vs addyi comparison helps clarify the trade-off: daily pill versus on-demand injection, plus different side-effect profiles.
| Feature | Addyi (flibanserin) | Vyleesi (bremelanotide) |
|---|---|---|
| How it is taken | 100 mg pill at bedtime, every day | Subcutaneous injection as needed before sex |
| Approved population | Premenopausal women with acquired, generalized HSDD | Same population |
| Typical side effects | Dizziness, sleepiness, nausea, fatigue | Nausea, flushing, headache, injection-site reactions |
| Alcohol | Must be avoided; boxed warning | No alcohol-related boxed warning |
| Blood pressure | Can lower it; fainting risk with alcohol | Can briefly raise it; avoid with uncontrolled hypertension |
Non-drug options deserve equal attention: sex therapy, couples counseling, treating underlying depression or anxiety, reviewing medications that suppress libido, and addressing relationship or hormonal factors. Many clinicians recommend these first or alongside medication.
How to Read Addyi Reviews Critically
A useful review states the reviewer's age group, diagnosis, dose, and how long they stayed on treatment. A review that omits all of that is an anecdote, not evidence.
Be equally skeptical of sites that blend prescription drug content with research chemicals. Addyi and Vyleesi have FDA-reviewed safety data; compounds discussed in aod 9604 reviews or cagrilintide reviews are typically sold as research chemicals and are not FDA-approved for human use.
No review can tell you whether Addyi is right for you. Talk with a healthcare professional who can review your history, medications, and blood pressure before you start.
Frequently Asked Questions
Does Addyi really work for low libido?
Addyi works for some women, but the average effect in trials was modest. Across two 24-week studies, women taking flibanserin reported roughly one additional satisfying sexual event per month compared with placebo, plus a small increase in desire and a larger drop in distress. Responders usually notice a difference after four to eight weeks. If there is no improvement by eight weeks, most clinicians recommend stopping the medication.
What are the most common side effects of Addyi?
The most frequently reported side effects are dizziness, sleepiness, nausea, fatigue, insomnia, and dry mouth. Addyi also carries a boxed warning for severely low blood pressure and fainting, especially when it is combined with alcohol. About 10% of women in the clinical trials stopped taking it because of side effects.
Is Addyi the same as flibanserin?
Yes. Addyi is the brand name for flibanserin, and both names refer to the same prescription medication. Addyi is FDA-approved for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Searching for flibanserin reviews returns the same drug, the same dosing, and the same clinical data.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.